Who we are
AIP-Lifesciences is an international service, advisory and investment firm focused on the global lifesciences sector. We provide a competitive range of flexible services that includes capital introduction, business development, principal investment, company incubation and acceleration, deal screening, research and business support, and accessing human capital.
Our entrepreneurial team serves a diverse range of industries and clients across investment and financial services, industry, and professional services. This includes corporates, investment banks, accountancy firms, management consultancies, and law firms amongst others. In addition, we serve a broad range of public and private market lifesciences-focused investors including institutions, private equity, family offices, hedge funds, sovereign wealth funds, endowments, foundations and many more…
- AI/ML
- Biotechnology
- Digital Health
- Healthcare
- Medical Devices
- Pharmacology
- R&D
Some numbers
Within our team
What we do
Our services
Principal Investment
Generating long-term capital growth by investing in the lifesciences sector both as principals and alongside a consortium of investment partners.
read moreINCUBATION & ACCELERATION
Establishing, structuring, staffing and raising capital for a broad range of customised lifesciences-focused businesses and investment platforms.
read moreCAPITAL INTRODUCTION
Providing capital introduction services to firms globally with extensive access to international investors across the private and public markets.
read moreSCREENING and ADVICE
Helping you to select and manage investments and personnel through carefully considered sector-focused due diligence and expert advice.
read moreBUSINESS DEVELOPMENT
Creating and augmenting your business development funnel through access to our international network of lifesciences-focused businesses and investors.
read moreHuman Capital
Providing international junior through to executive level recruitment services on a permanent, consultancy and real-time basis.
read moreORIGINATION
Sourcing new investment opportunities for our clients from both the public domain and AIP’s specialist opportunity origination network.
read moreBusiness Support
A lifesciences concierge service. This has included Equity Research, Asset Modelling, Web Application Development, Video Production and IR assistance.
read moreMEET A FEW OF OUR TEAM
WHAT SETS US APART
Our DIFFERENTIATORS
Our Team
Partner with a team of best in class industry, banking and finance and professional services experts.
Our Access
Benefit from our market relationships and access to over 50,000 lifesciences professionals.
Our Track Record
Leverage our exceptional track record of delivery across a range of industries, transactions and service offerings.
A few examples of current work
AIP has an exceptional track record of delivery across the lifesciences sector.
Our team is regularly engaged to deliver value to clients across a diverse range of markets and geographies. This includes opportunities to raise and deploy capital, to build new business, to create new management teams and companies, to assist with sourcing and screening new investment opportunities, and to provide on-call research and business support services. Read about a few of our existing mandates opposite. For more information, please get in touch.
• AIP has been mandated to raise $250m for an established lifesciences venture fund to invest in a portfolio of North American and European early stage companies.
• AIP has been mandated to raise $10m series A round for a new AI/ML-focused healthcare and pharma company using AI for drug discovery.
• AIP has been mandated to raise $20m for a clinical-stage biopharma company focused on discovering and developing innovative small-molecule drugs.
• AIP is currently in the process of building a new drugs company with an exclusive licence to commercialise in the US and UK. The focus of the company build out includes establishing a UK entity, building the UK management team (operations and sales), engaging discussions with the NHS and other groups, managing all legal and commercial activities, and raising additional capital for business expansion.
• AIP was engaged by a recently funded healthcare start-up to help build their new business development pipeline. The engagement included our research team mapping prospective new business leads who included corporates, healthcare trusts, and private hospitals. Following agreement of the target list, AIP’s team of new business consultants reached out directly to the leads via telephone, email and business social media. This was followed by numerous video telephone calls which led to qualified introductions to our client.
• AIP has been retained by a multi-family office to source up to $250m of healthcare and pharma investments with view to customising an investment portfolio. A decision will be taken by the family office on whether to invest in and manage their own portfolio or to invest via a healthcare-focused venture capital fund.
• AIP has been mandated by a major venture capital fund to source the latest seed and series A opportunities across digital health, AI/ML-focused healthcare and medical devices. The minimum deal size is $5m.
• AIP created a private introductory video for one of our digital health clients for an AIP investment webinar. The video was professionally produced by our video consultant and narrated by a BBC narrator.
• AIP and our legal counsel created a customised term sheet for a series A client who wished to use the Channel Islands for the location of the company. This also meant introducing a Channel Islands based Non-Executive Director.
• AIP created a complete business plan for a new start-up to use for fundraising. The business plan focused on a description of the business, market strategies, competition analysis, design and development, operations and management, and financial information.
AIP was mandated to hire the executive business team of a series B company. Through our DRS relationships/shareholding, we hired and onboarded the following personnel:
- Non-Executive Chairman
- COO
- Finance Director
- Head of Sales
- Head of Client Engagement
AIP is currently involved in principal investment activities with a new AI/ML company that focuses on R&D across a number of business areas, most notably in healthcare and pharmacology. The company is currently developing the latest algorithms, processes, models and techniques for specialist lifescience-focused AI/ML application areas.
AIP has been mandated to provide multiple research projects for several clients in the past quarter. A few of these include:
- Create an investor directory of all lifesciences-focused family offices worldwide
- Create an investor directory of UHNWi in North America with a net worth >$200m
- Create an investor directory of all pharma-focused VC and CVC investors worldwide
- Create a list of all healthcare and pharma companies founded in the past 3 years and amounts raised ($USD
- Build a C-level Linked-In network directory for a healthcare founder/CEO
- Build a competitor map for a new digital healthcare start-up
AIP has been mandated to provide objective views on a number lifesciences companies and funds. These included:
- Blood glucose monitoring company
- In vitro diagnostic solutions company
- Pharmacy information technology company
- Biopharmaceutical company for serious diseases and medical conditions
- Health and wellness information company
- AI-focused primary healthcare company